LIPO - LIPELLA PHARMACEUTICALS INC.

QQQ $ 463.74 $ 0.15 (0.03 %)

DIA $ 400.12 $ 2.30 (0.58 %)

SPY $ 543.85 $ 1.71 (0.32 %)

TLT $ 97.88 $ 0.61 (0.63 %)

GLD $ 226.19 $ -1.86 (-0.82 %)

Previous Close

$ 0.4359

Open

Bid

$ 0.54 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.36 - $ 2.71

Volume

45,868

Average Volume

Market Cap

3.32M

Beta (5Y Monthly)

$ -0.40

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-27-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-12-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lipella Pharmaceuticals Begins Phase 2a Tr...
08/12/2024 09:01:52

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) ("Lipella," "our," "us," "we" or the "Company...

Lipella Pharmaceuticals Announces $1.28M R...
08/01/2024 12:07:05

Lipella Pharmaceuticals Inc. ("Lipella" or the "Company") (NASDAQ:LIPO), a clinical-stage biotechnology company...

dow-edges-lower-ventyx-biosciences-shares-plummet

Dow Edges Lower; Ventyx Biosciences Shares...
07/29/2024 18:31:47

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

crude-oil-moves-lower-nls-pharmaceutics-shares-jump

Crude Oil Moves Lower; NLS Pharmaceutics S...
07/29/2024 16:03:54

why-lipella-pharmaceutical-shares-are-soaring-today

Why Lipella Pharmaceutical Shares Are Soar...
07/29/2024 15:28:17

Lipella Pharmaceuticals shares are trading higher Monday after the company announced the enrollment of the first patients in it...

nasdaq-gains-1-mcdonalds-posts-downbeat-results

Nasdaq Gains 1%; McDonald's Posts Downbeat...
07/29/2024 14:12:22

Market-Moving News for July 29th
07/29/2024 12:22:29

LGVN: 49% | Longeveron Announced Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B In Mild Alzheimer's Di...

Lipella Pharmaceuticals Commences Phase 2a...
07/29/2024 09:04:57

Lipella's Phase 2a trial is a multi-center, dose-ranging study of LP-310, a proprietary liposomal-tacrolimus oral rinse for...

why-asp-isotopes-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-fridays-mid-day-session

Why ASP Isotopes Shares Are Trading Lower ...
07/12/2024 17:14:56

why-ericsson-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Ericsson Shares Are Trading Higher; He...
07/12/2024 09:35:41

Lipella Pharmaceuticals Completes Site Ini...
05/31/2024 12:04:23

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
05/22/2024 12:06:41

Lipella Reveals Receipt Of FDA Type-C Meet...
05/21/2024 12:05:48

Lipella expects to initiate a Phase 2b clinical trial evaluating LP-10 as a treatment for hemorrhagic cystitis in approximately...

clearside-biomedical-and-3-other-penny-stocks-insiders-are-buying

Clearside Biomedical And 3 Other Penny Sto...
05/16/2024 11:55:49

why-natera-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket

Why Natera Shares Are Trading Higher By 15...
05/10/2024 12:44:22

Maxim Group Initiates Coverage On Lipella ...
04/09/2024 15:36:55

Maxim Group analyst Jason McCarthy initiates coverage on Lipella Pharmaceuticals (NASDAQ:LIPO) with a Buy rating and announc...

Lipella Pharmaceuticals To Publish Abstrac...
04/05/2024 12:00:54

Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Announces FDA Type...
04/03/2024 12:02:39

why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why SOPHiA GENETICS Shares Are Trading Low...
03/05/2024 18:11:47

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...